Need help?

Pharmaceutical Business Investment Opportunities

Showing 1 - 15 of 192 Pharmaceutical Business Investment Opportunities. Invest in a Pharmaceutical, Alternative Medicine, Biopharmaceutical, Diagnostic Substance Manufacturing, Generic Pharmaceutical, Specialty Pharmaceutical, Veterinary Drug, Nutraceutical or a Pharma Marketing Business.

Filters
  • Pharmaceuticals

  • Investment Opportunities

 

Profitable Nutraceuticals Company Investment Opportunity in Oslo, Norway

Healthcare solution providers with 1,50,000 current customers and business partners seeking financial investment.
- We are a global innovative integrated healthcare solution provider currently focusing on nutraceuticals and pharmaceutical products. - Operate in network marketing through D2C and B2B sales models. - Have more than 1,50,000 current customers and business partners in 30+ countries in the US and Europe. - Manufacturing is done on a contract basis. - We have FDA and ENA licenses. - Promoters have 20-30 years of experience in the industry. - We do not require a large number of employees as manufacturing is outsourced.
8.3   Oslo
Run Rate Sales
USD 120 million
EBITDA Margin
10 %
Financial Investment
USD 5 Mn for 5%
Contact Business

Nutraceuticals Company Investment Opportunity in Subang Jaya, Malaysia

Seeking investment: RTD sleep-aiding functional beverage in the SEA available in 600+ retail stores.
- We manufacture sleep-enhancing drinks. - The drink is manufactured on an OEM basis through our contract manufacturers. - Product is available across 600+ retail outlets in Malaysia including popular convenience chain stores and pharmacies. - Ready to sell in Singapore with required permits acquired. - Being a finalist of the FoodBev award in 2022 for most innovative functional beverage. - Formulated by proprietary formula with natural ingredients. - Planning to launch a series of branding and marketing strategies to boost brand awareness and offline product activation. - Have read offline channels to increase the physical selling spots of products. - Have the formula of new products ready for production and go-to-market. - The promoter has 2 years of experience in this industry and has previously been involved in the eCommerce and supply chain industry. - The business has a local authority certificate, factory certificate, and HACCP compliance certificate. - The business is currently operating at a loss as the business is still in the startup phase.
7.2   Subang Jaya
Run Rate Sales
USD 38 thousand
EBITDA Margin
Operating at loss
Financial Investment
USD 200 K for 20%
Contact Business

Pharma Marketing Company Investment Opportunity in New Delhi, India

Generic medicines distribution (B2B) network with huge scope in the country.
- Currently focusing on the B2B category and acquiring new retails for the supply of generic medicines. - Currently managing 17-20 clients and selling them more than 10 crores of generic medicines per annum. - Our revenue model is earning through the trade and supply of generic medicine from distributors network to the retailer.
8.4   New Delhi
Run Rate Sales
USD 1 million
EBITDA Margin
20 - 30 %
Financial Investment
USD 240 K for 20%
Contact Business

Newly Established Generic Pharmaceuticals Company Investment Opportunity in Dhaka, Bangladesh

Pharma manufacturing business with 52 years of history and 43 patents, seeking investment for revival.
- Pharmaceutical business located in Dhaka, Bangladesh, has a rich history of 52 years in the industry, having recently been acquired by new management. - The brand, licenses, registrations, client base, and property have been transferred to the new owners. - Was supplying across Bangladesh, the Middle East, and African countries under its own branding. - The business was temporarily closed down three years ago due to personal reasons, but it is now in the process of re-establishing existing contracts and resuming production. - With 43 patents from medical authorities and various licenses including drug manufacturing, IRC, and Export & Import, the company has a strong foundation for pharmaceutical production and distribution. - The pharmaceutical company manufactured a diverse range of drug formulations, including liquid, capsule, tablet, suspension, syrup, injection, aerosol spray & inhaler, injections, bolus, premix powder, premix solutions, and bulk drugs. - Manufactured drug categories include - antibiotics, antibacterials, chemotherapeutics, antiprotozoals, antidiarrhoeal, antidiabetic, antihistamines, NSAIDs, antihypertensives, multivitamins etc. - The company possesses a broad client base, serving wholesalers, pharmacies, hospitals, clinics, and distributors, indicating its reach and potential for growth in both domestic and international markets. - Revenue will be primarily generated through the sale of generic medications, with a focus on cost-effective production and competitive pricing strategies, positioning the business well for market success. - The company is led by experienced professionals with a background in pharmaceutical manufacturing, research, and business management, indicating strong leadership and expertise within the organization. - Had established strong relationships with suppliers of raw materials, regulatory authorities, distribution partners, and healthcare institutions. Have started re-establishing existing contracts and will restart the supply. Will continue to manufacture under the existing brand. - Additionally, the current owners are into manufacturing and supplying medical equipment to hospitals and healthcare facilities, thereby providing an opportunity to establish new contracts.
6.9   Dhaka
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 36 Mn for 50%
Contact Business

Newly Established Generic Pharmaceuticals Business Investment Opportunity in Gangasagar, India

Seeking investment to start a pharmaceutical drug manufacturing business in West Bengal.
- Business owner of a drug wholesale business planning to establish a pharmaceutical drug manufacturing plant. - The focus will be on creating a portfolio of drugs under the company's own brand name. - Initially, the manufacturing will concentrate on oral tablets and capsules, with future plans for expansion into other drug categories. - The company aims to supply its products to distributors across West Bengal, Jharkhand, Bihar, and Odisha. - Raw materials for the manufacturing process will be sourced from Ahmedabad and Visakhapatnam. - Will be obtaining drug license and FDA approval once the business launches.
6.4   Gangasagar
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 600 K for 50%
Contact Business

Alternative Medicine Company Investment Opportunity in New Delhi, India

Retailer with 900 outlets in India and targeting 5,550 outlet manufacturing capacity.
- Established Ayurvedic products manufacturer and retailer based in New Delhi. - We have 850 outlets across India. - We are well placed in ecommerce platforms like Amazon, Flipkart, Snapdeal Shopclues and 1Mg. - We also export our products to London and Mauritius. - Our capacity is 50,000 units per week. - We have an Ayurvedic License and pollution certificate from the State Pollution Control Board. - We source our raw materials from the open market. - We have contract and daily wage employees. - Our operations are run from New Delhi.
8.1   New Delhi
Run Rate Sales
USD 4.3 million
EBITDA Margin
8 %
Financial Investment
USD 360 K for 49%
Contact Business

Nutraceuticals Business Investment Opportunity in Colombo, Sri Lanka

Sri Lankan pharmaceutical distributor with 400 customers, seeking financial investment to import branded calcium product.
- Established nutraceuticals and cosmeceuticals distributor based in Colombo, dealing in imported products in the Sri Lankan market. - We are currently working with 7-8 suppliers, primarily in India, but we also import from New Zealand. We are in talks with a company in Italy as well. - Our order sizes range from 7,000-8,000 units and the value is usually around $15,000. - We promote the products to doctors through marketing and sales reps. - We currently have 400 doctors and chemists as our customers. - We have product authority from the Sri Lankan government.
Sri Lankan pharmaceutical distributor with 400 customers, seeking financial investment to import branded calcium product.
6.9   Colombo
Run Rate Sales
USD 300 thousand
EBITDA Margin
40 %
Financial Investment
USD 16 K for 30%
Contact Business

Pharma Marketing Business Investment Opportunity in Dhangadhi, Nepal

Wholesaler of medicines and distributor of many companies.
- Wholesaler of generic medicines. - Our customers are pharmacies and hospitals. - 3 full-time employees including 1 accountant, and 2 marketing staff. - Licensed to sell generic pharmaceuticals.
6.4   Dhangadhi
Run Rate Sales
USD 180 thousand
EBITDA Margin
15 %
Financial Investment
USD 45 K for 20%
Contact Business

Generic Pharmaceuticals Company Investment Opportunity in Colombo, Sri Lanka

Company looking to manufacture and supply tablets to the government of Sri Lanka seeks investment.
- The project is to manufacture and supply tablets to the government of Sri Lanka up to 860mln per annum on a buyback guarantee and cost plus 20% margin. - The company can sell also in the private market which has a 40% profit margin. - Own 9.25-acre land valued at USD 1mln approx. - The license is issued and a government buyback agreement is signed. - The project is in plug and play stage where the investor can mobilize immediately. - Commercial manufacturing can commence in 8 months.
6.9   Colombo
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 15 Mn for 75%
Contact Business

Nutraceuticals Company Investment Opportunity in Srebrenik, Bosnia and Herzegovina

Nutraceuticals company, based in Bosnia with > €6 million annual revenue, 45,000 orders to date.
- Nutraceutical manufacturing, tech marketing & sales company, based in Srebrenik, Bosnia. - Our products are nutraceutical supplements for common disease conditions such as, prostate, hemorrhoids, diabetes and hypertension weight loss and hair loss. - Planning to launch products for more disease conditions such as psoriasis and other skin conditions. - Our clients are individual customers from countries across Eastern Europe such as Serbia, Croatia, Romania etc. Planning to expand to other European countries as well. - We get about 3 to 4k orders every month. Average value of each product is EUR 75. - Manufacturing capacity is 70k products everyday. - Since its inception, the company has showcased significant financial growth, with revenues escalating from €700,000 in 2021 to €5 million last year, and anticipated revenue of around €6 to €7 million for this year. - Till date, we’ve successfully crossed over 45,000 orders, evidencing strong market engagement. - Our seasoned leadership team has been instrumental in nurturing valuable industry relationships. - Our innovative in-house SaaS projects have bolstered our operational prowess: our affiliate network; an ads tracking software; a call center software enhancing our sales processes and a website builder facilitating seamless online presence. - There are 98 permanent employees. Additionally, we have 200+ contract marketing partners. - The company has ISO, GMP, and MoH licenses.
Nutraceuticals company, based in Bosnia with > €6 million annual revenue, 45,000 orders to date.
7.4   Srebrenik
Run Rate Sales
USD 6.5 million
EBITDA Margin
13 %
Financial Investment
USD 5.4 Mn for 20%
Contact Business

Nutraceuticals Company Investment Opportunity in Auckland, New Zealand

First-to-market D2C B2B nutraceutical ingredient and supplement company seeks investment for expansion.
Gold-standard research has established our product as an elite, unique breakthrough branded ingredient and finished goods that have been commercially tested and proven in the Australasian and UK marketplace. As a supplier to English Premier League football clubs, and high-performance sports organizations in the UK and New Zealand, our product is used in elite sports to provide a proven competitive advantage. We have an official New Zealand All Blacks, product and collaborate with sports supplement companies such as Healthspan Elite and Science in Sport. Aside from finished goods, we are launching a branded ingredient, where very few possess the volume of clinical, making a high-growth potential product in the US and EU. With restrictions on health claims in the EU, our finished goods marketing strategy is focused on the US, where we entered the market late last year, with a modest marketing budget. Our unique provenance story centers around NZ’s powerful climate, which produces an exceptional polyphenol-rich berry fruit unique to the region. With concentrations and combinations of bioactive not present in any other berry, our fruit is key to producing a high-quality, high-potency extract that delivers a host of antioxidant, vasodilatory, and anti-inflammatory actions. The product’s exceptional multiplicity of physiological properties has led to international brand recognition, with five Sports Nutrition Product Champion awards (Nutra Ingredients/ESSNA - Europe, USA, Asia), and three Best Recovery Product titles (UK, Europe). We have been shortlisted once again for the Champion Sports Nutrition Award in Europe this year. With our product name-checked in all published studies, our material and science are responsible for many of the major anthocyanin-derived breakthroughs of the last decade. Our current combined revenues are operating at approx USD 650,000 from our small business enterprises in the UK, NZ, and Australia. As the first-to-market New Zealand blackcurrant brand, the company’s primary focus is to capitalize on a decade of research investment and development. A well-supported sales and marketing strategy can leverage this rare offering with the right strategic partner. Manufacturing is done by a third party and we hire temporary staff for other work so we do not have much permanent staff. Sales will pick up in the coming months due to new orders and clients.
7.5   Auckland
Run Rate Sales
USD 450 thousand
EBITDA Margin
40 %
Financial Investment
USD 5 Mn for 50%
Contact Business

Pharma Marketing Company Investment Opportunity in Hubballi, India

Established pharmaceutical company with trademarked products and 2,500 B2B customers; seeking investment to expand.
• Established Pharmaceutical company based in Hubbali. • Products include Gynac, Cardiac and GP segment tablets, as well as innovative brands in ORS and Gynecology treatment. • 2,500 B2B customers, as well as our own pharmacy retail. • Working with 4 manufacturers to produce own brand products, with 4 brands with trademark. • Order 5,000 strips from manufacturers based on need basis. • Our sales have dropped this year due to shortage of funds. • The business has a drug license.
5.9   Hubballi
Run Rate Sales
USD 36 thousand
EBITDA Margin
30 %
Financial Investment
USD 120 K for 15%
Contact Business

Specialty Pharmaceuticals Company Investment Opportunity in Visakhapatnam, India

New biopharmaceutical company with a primary focus on plasma fractionation to manufacture therapeutic plasma proteins.
● Our business has already obtained DCGI approval to manufacture the following proteins in the R&D Unit for the purpose of research and analysis. ● Our R&D unit is set up in 2,000 sq ft space in MN iHub, GenomeValley, Turkapally, Hyderabad with 3 state-of-the-art designated lab spaces for process development, analytical R&D and quality control with a total of 25 staff members. ● Our protein samples are already been extracted and stability studies are being done. ● 150,000 sq ft manufacturing facility is under contraction and will be completed soon. ● By the time the business starts operations, we will have 200 employees. ● Founders are based in the US.
7.1   Visakhapatnam
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 4 Mn for 10%
Contact Business

Pharma Marketing Company Investment Opportunity in Chennai, India

Leading distributor for Cipla, Sun Pharma, and C/F for Abbot & Alkem seeks expansionary funding.
- We deal with more than 1,500 customers. - Customers include pharmacies, hospitals, and other wholesalers. - Our customer base and revenue have grown by 20% every year. - Equal revenue split across all customer categories. - We are leading distributors for Cipla, Sun Pharma Alkem, and 70 more companies. - We are a C/F for Alkem, Abbot, Aristo, Laborate, Aqualab, and Troikaa. - The owner has an experience of 34 years in the industry. - The revenue seems high due to the high volume as we are wholesalers. However, our margins are very thin at about 5-6%.
Leading distributor for Cipla, Sun Pharma, and C/F for Abbot & Alkem seeks expansionary funding.
8.9   Chennai
Run Rate Sales
USD 7 million
EBITDA Margin
5 %
Financial Investment
USD 2.4 Mn for 50%
Contact Business

Alternative Medicine Company Investment Opportunity in New Delhi, India

Invest in ayurvedic medicinal cannabis company with 1,000+ products sold, 10 SKUs targeting different ailments.
✔️ Aim to revive ayurveda medicinal cannabis, combining ancient practices with cutting-edge research. ✔️ 1,000+ products sold. ✔️Network of doctors prescribing our products. Partnership with government and private hospitals/institutions, medical/ayurvedic clinics/colleges, and corporates. ✔️Listed on Amazon and other E-commerce portals. Our distribution network is established across India and globally. ✔️Ongoing pre-clinical trial for Hemp Seed oil and Hemp seed oil-related products. ✔️ 10 SKUs targeting different ailments. The business is set to add more proprietary and classical medicines. ✔️ Received the approvals for Hemp based products for future launches (first time in India) ✔️ Net revenue for the latest FY- INR 24 lakhs and gross revenue of INR 36 lakhs without any marketing. ✔️Awards: Top 10 D2C emerging startups in Delhi NCR by Entrackr and Bharat x, CC Avenue, and IDFC bank. ✔️ Recently opened a wellness center in Himachal Pradesh. ✔️ The company needs the current number of employees for its digital growth.
9.4   New Delhi
Run Rate Sales
USD 35 thousand
EBITDA Margin
18 %
Financial Investment
USD 500 K for 23%
Contact Business

Frequently
Asked
Questions

  • How many pharmaceutical business investment opportunities are listed on SMERGERS?
    There are 192 active and verified pharmaceutical business investment opportunities listed on SMERGERS as of 29 February 2024.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more